Episodios

  • Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller
    May 21 2026
    The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could actually support. That gap created a backlash the legitimate medical thesis didn't deserve. What's left on the other side of the green rush is a near-complete forgetting of the reason this industry started in the first place. The medicine. Now the infrastructure to prove it is finally in place. Standardized genetics. Reproducible extraction. Full compound characterization. An FDA botanical drug pathway that has existed since 2016 that most investors have never heard of. Organic medicine versus synthetic single-molecule will be a real choice at the pharmacy counter sooner than most people expect. The foundational work is already here. This week we sit down with Joel Stanley and Dr. Marcel Bonn-Miller: Botanical drugs vs. supplements6,000 compounds, one drugNovel compounds nobody has named yet Chapters 00:00 Why Medical Validation Remains a Challenge for Cannabis 00:12 The FDA Approval Process for Plant-Based Medicines 01:03 Historical Market Dynamics and Their Impact on Cannabis Perception 02:48 Removing the Veil: How Science Can Validate Cannabinoid Therapies 03:15 The Complexity of Plant Molecules and Real-World Evidence 06:20 Focus in Drug Development: The Case of Autism Spectrum Disorder 07:10 The Impact of Charlotte's Web and Media Hype 08:52 Balancing Hype and Reality in Cannabinoid Medicine 10:01 Legitimization of Cannabis Research in Academia 12:10 The Evolution of Cannabis Research and Acceptance 13:54 The Future of Botanical Medicine and Academic Research 16:15 The Long Road of Drug Development for Cannabis-Based Medicines 20:50 Introducing AJA-001: A Botanical Drug for Autism 22:44 Standardization and Characterization of Botanical Drugs 24:01 Partnerships and Funding in Botanical Drug Development 24:40 Challenges of Multi-Compound Botanical Drugs 27:28 Reproducibility and Quality Control in Botanical Manufacturing 29:06 FDA Pathways for Botanical Drugs and New Chemical Entities 34:29 Identifying and Characterizing Thousands of Plant Compounds 39:48 The Role of AI and Supercomputing in Drug Discovery 41:11 Balancing Exploration and Focus in Botanical Research 44:38 What the World Will Understand About Cannabinoids in 10 Years 47:24 The Promise of Botanical Medicine Over Single Molecule Drugs Guest Links: AJNA Biosciences Websitehttps://ajnabiosciences.com/ AJNA Biosciences LinkedInhttps://www.linkedin.com/company/ajna-biosciences/posts/?feedView=all AJNA Biosciences Instagram @ajnabiosciences Charlotte’s Web Websitehttps://www.charlottesweb.com/ Charlotte’s Web LinkedInhttps://www.linkedin.com/company/charlottesweb/posts/?feedView=all Charlotte’s Web Instagram @charlotteswebcbd Joel Stanley LinkedInhttps://www.linkedin.com/in/joel-stanley-2885116b/ Joel Stanley Instagram @joel.stanley Dr. Marcel Bonn-Miller LinkedInhttps://www.linkedin.com/in/marcel-bonn-miller-897a581/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    Más Menos
    51 m
  • Joe Lustberg: What Cannabis Lenders See That Operators Miss
    May 15 2026

    The number in your head and the number you actually need are not the same number. That gap is where most cannabis businesses break.

    Joe Lustberg has financed operators across the country for years and watched that gap swallow businesses that looked fine on paper. He has also spent over two years paying rent on a Hamptons dispensary he cannot open because a municipality tried to rezone his property out from under him. The person telling you to build in 1.5X as your burn capital cushion has been living inside exactly the scenario he warns everyone about.

    When the lender financing your industry has lived the same nightmare, the advice changes.

    This week we sit down with Joe Lustberg, to discuss the following

    • NY Regulatory Battlefield
    • 280E Gone: What Changes
    • Lending Specifics

    Chapters

    00:00 Navigating the Cannabis Landscape: A Personal Journey

    02:51 Understanding the Financial Risks in Cannabis Operations

    06:01 The Importance of Burn Capital for Cannabis Startups

    09:02 Lending Dynamics in the Cannabis Industry

    11:55 Market Trends and the Future of Cannabis Financing

    14:51 The Impact of Rescheduling on Cannabis Operators

    18:01 Identifying Strong Operators in a Competitive Market

    21:05 Evaluating Financial Health: Key Indicators for Success

    26:01 Evaluating Limited Markets: The Ohio Perspective

    28:24 Navigating Unique Financing Requests

    29:12 Surprising Success Stories in Cannabis Financing

    32:04 The Importance of Experience in New Ventures

    35:46 Identifying Undervalued Markets in Cannabis

    38:00 The Future of Cannabis Markets and Interstate Commerce

    Guest Links

    https://www.linkedin.com/in/joseph-lustberg-23076722

    Our Links:

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    44 m
  • The Hidden Margin Killer for MSOS ft. Braunz Muller
    May 8 2026

    Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used to justify the wrong decision. Overproduction cycles, steep discounting, margin pressure building back into manufacturing: most of that traces back to data being used reactively instead of as a decision guidance tool.

    Layer on the reality of multi-state operations where every market runs a different system, tracks different items, and reports differently. Making sense of what the numbers are actually saying across that footprint isn't just a technology problem. It's an interpretation problem with real financial consequences.

    Think of it like a compass that's slightly off calibrated. Over a short distance, no one notices. Across 15 facilities and hundreds of SKUs, you end up miles from where you intended.

    This week we sit down with Braunz Muller, to discuss the following

    • Margins in Cannabis Supply Chains
    • Hydrocarbon SOP Secrets
    • THC Efficiency as the Real KPI

    Chapter

    00:00 Data Problems in Cannabis Manufacturing

    12:50 The Complexity of Decision-Making

    20:31 Dynamic SOPs in Extraction

    30:14 Balancing Flexibility and Control in Operations

    32:08 Empowering Operators Within Structured Systems

    35:03 The Importance of Data in Extraction

    39:27 Understanding Yield and Efficiency

    43:00 Closing the Loop in Extraction Processes

    48:40 Optimizing Cultivation for Better Efficiency

    54:04 Auditing for Efficiency in Manufacturing

    56:51 The Future of Hydrocarbon Extraction Knowledge

    Guest Links:

    linkedin.com/in/braunz-muller-98382018b

    Our Links:

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    58 m
  • Ed Rosenthal and Greg Baughman: You're Still Growing Cannabis Wrong
    Apr 24 2026

    A customer walks into the dispensary and asks the budtender for a flower recommendation.

    They end up with a degraded version of the once high-end flower that graced your cultivation floor. They do not know it. Your brand took the blame.

    Ed Rosenthal, the most referenced name in cannabis cultivation history, says the cannabis supply chain has a freshness problem that starts in the dry room and compounds at every handoff. The smell of your drying room that everyone loves walking into? Those are your terpenes leaving the building.

    This week we sit down with Ed Rosenthal and Greg Baughman to discuss:

    How Canada already solved this
    Why most are still cultivating wrong
    Freeze drying vs. traditional drying

    Chapters

    00:00 The Freshness Debate: Cannabis vs. Produce

    03:01 Consumer Awareness and Dispensary Practices

    05:55 Post-Harvest Processing: Ensuring Quality and Consistency

    08:59 Innovations in Freeze-Drying Cannabis

    11:48 The Science Behind Freeze-Drying: A Deeper Dive

    14:52 Testing and Refining the Freeze-Drying Process

    17:54 The Future of Cannabis Processing: Quality and Efficiency

    28:28 Post-Harvest Efficiency and Cost Reduction

    30:26 Cultivation Methods and Labor Costs

    35:09 Crisis Management and Industry Change

    39:22 Market Maturity and Operational Efficiencies

    43:00 Future of Cannabis Cultivation

    47:04 Innovations in Drying and Curing Processes

    52:46 Consumer Perception and Quality Assurance

    Guest Links:

    • http://cryocure.com/
    • https://www.linkedin.com/in/greg-baughman-2869b4218/
    • https://www.linkedin.com/in/edrosenthal-/
    • https://www.linkedin.com/company/cryocurecannabis/

    Our Links:

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    55 m
  • The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli
    Apr 6 2026

    The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap.

    Aubrey Amatelli left JP Morgan believing that if you followed the rules, aligned with card brand requirements, and structured things correctly, you could build a compliant, stable payment product. Then came Mastercard shutdowns, a failed tech partner that cost six figures, and a stretch where 5,000 dispensaries lost payment access in a matter of weeks. What came out of that was a different approach to building in cannabis. Redundancy is not a feature. It is the product.

    This week we sit down with Aubrey Amatelli to discuss the following:
    • JP Morgan to cannabis payments
    • A failed partner and six figures lost
    • Why moving from cash to card changes ticket size

    Chapters

    00:00 Navigating the Cannabis Payment Landscape

    02:55 Understanding Payment Processing Challenges

    05:57 Building Redundancies in Payment Solutions

    09:02 The Impact of Federal Legislation on Payments

    12:08 Consumer Education and Payment Solutions

    15:03 Product Development and Market Needs

    18:02 The Evolving Nature of Cannabis Payments

    21:28 Navigating Cannabis Payment Solutions

    22:12 The Rise of Cryptocurrency in Alternative Medicine

    26:36 The Future of Cannabis Banking and Federal Legalization

    30:22 AI's Role in Payment Processing

    33:57 Understanding Payment Processing Challenges in Cannabis

    37:10 The Importance of Average Ticket Growth

    Guest Links

    https://www.linkedin.com/in/aubreyamatelli/

    https://payrio.co/

    Our Links

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    41 m
  • Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed
    Mar 27 2026

    Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem.

    Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them in the back, push them down the stairs, and take credit for the fall. It's time to put fear behind cannabis.

    She spent 20 years on Capitol Hill. She's watched cannabis show up once a year for fly-ins, throw money at the wrong politicians, and wonder why nothing changes. This episode breaks down why incrementalism is the only path, why banking matters more than you think, and why the industry needs to stop picking out curtains when it hasn't built a basement.

    This week we sit down with Gretchen Gailey:

    • Stab them in the back politics
    • Curtains before basement problem
    • Project Champion playbook

    Timestamps:

    00:00 - The industry's fundamental misunderstanding about Washington politics

    02:35 - Challenges with incrementalism versus desire for rapid change

    04:47 - Supporting pro-cannabis politicians like Cynthia Loomis

    06:45 - The role of education and public awareness campaigns

    10:06 - Building a basic regulatory foundation: banking, safe products, and rescheduling

    13:23 - The limitations of state-led models and the need for federal coordination

    15:50 - The importance of transparency and federal standards for consumer safety

    18:43 - The influence of political operatives and the importance of direct advocacy

    22:51 - Using industry tools and data to inform policy and educate policymakers

    26:15 - The significance of Congressional engagement and how to make cannabis an urgent issue

    30:10 - The importance of political will and executive orders in advancing reform

    34:40 - The disconnects within Washington and how industry can better influence policy

    37:19 - Opportunities in leveraging symbolism like Veterans issues and Congressional events

    41:14 - The disconnect between access and influence, and how to effectively make the case

    44:40 - The necessity of creative strategies, public pressure, and celebrity involvement

    50:21 - Successful stories: case of Cory Booker and the impact of direct constituent advocacy

    52:16 - Final thoughts: how to stay engaged and educate the industry and policymakers

    Summary:

    In this episode, Gretchen Gailey shares over 20 years of experience navigating Washington's complex cannabis legislation. We explore how industry players can effectively engage with policymakers, the importance of foundational regulations, and strategies to accelerate federal progress on cannabis reform.

    Guest Links:

    • https://www.linkedin.com/in/gretchengailey
    • https://projectchampion.org/
    • https://x.com/GretchenGailey

    Our Links

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    53 m
  • 15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt
    Mar 19 2026

    Investing in cannabis requires a split personality.

    Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that followed. His take: if you've been through multiple pump-and-dump cycles, you're not early anymore. You're just still here.

    This is a masterclass in separating trader psychology from fundamental conviction. Dan explains why he keeps a small position just to stay seated, why he already knows he'll sell early on the next catalyst, and why the moment everybody's talking about cannabis on Wall Street Bets is the moment you size up — not before.

    This week we sit down with Dan McDermitt:

    • The "I'm early" delusion
    • Why traders sell early
    • Catalyst stacking thesis
    • MSOS mechanics breakdown

    Chapters

    00:00 The Catalyst Dilemma in Cannabis

    03:03 Trading Strategies and Market Positioning

    05:48 Understanding Trader vs. Fundamentalist Perspectives

    08:46 The Unique Nature of MSOS Trading

    11:51 Market Dynamics and Trading Psychology

    15:03 The Role of Uplisting and Rescheduling

    18:08 Long-Term Perspectives in a Volatile Market

    21:04 Risk Management and Trading Mindset

    23:51 The Impact of AI on Trading Strategies

    Summary

    In this conversation, Bryan Fields and Dan McDermitt discuss the current state of the cannabis market, focusing on the challenges and opportunities within the sector. They explore the impact of potential rescheduling and uplisting on cannabis stocks, the differences between trading and fundamental analysis, and the unique trading dynamics of MSOS. Dan shares insights on risk management, trading psychology, and the influence of AI on trading strategies, emphasizing the importance of adapting to market conditions while maintaining a disciplined approach.

    Guest Links:

    • https://x.com/ChartGuys
    • https://www.instagram.com/chartguys/
    • https://www.youtube.com/@ChartGuys
    • https://www.chartguys.com/

    Our Links

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    40 m
  • Premium vs Scale in Cannabis: Inside Rubicon’s Strategy ft. Margaret Brodie
    Mar 13 2026

    Most cannabis companies chased scale. Rubicon chased quality.

    What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why consumers only give brands one chance, how Rubicon evaluates resource capacity and audits operations, and why Europe could become the next meaningful opportunity for their trusted brands.

    This week we sit down with Margaret Brodie, CEO of Rubicon Organics:

    • Why premium cannabis starts with flower
    • Consumers Trust
    • Internal Resource Audits

    Chapters

    00:00 Quality Over Quantity in Cannabis

    02:58 Building a Premium Cannabis Brand

    05:47 Operational Excellence and Team Culture

    09:04 The Pursuit of Continuous Improvement

    11:45 Understanding Consumer Trust and Brand Loyalty

    14:45 Strategic Decision-Making in Cannabis

    18:06 Navigating Industry Challenges and Opportunities

    27:55 Navigating the Fast-Paced Cannabis Industry

    29:13 Investment Priorities for Growth

    31:43 Strategic Market Expansion and Brand Development

    35:08 Building a Lasting Brand in Cannabis

    37:20 Learning from International Markets

    40:56 Balancing Speed and Quality in Growth

    42:51 Understanding Consumer Dynamics

    46:06 Honoring the Legacy Market

    49:30 Reflecting on the Journey and Future of Cannabis

    Guest Links

    https://www.instagram.com/rubiconorganics/

    https://www.rubiconorganics.com/

    https://x.com/RubiconOrganics

    Our Links

    Bryan Fields on Twitter

    Kellan Finney on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    51 m